529 related articles for article (PubMed ID: 20447725)
1. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
2. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
Gallitelli M; Alzetta M
Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Baş M; Greve J; Stelter K; Havel M; Strassen U; Rotter N; Veit J; Schossow B; Hapfelmeier A; Kehl V; Kojda G; Hoffmann TK
N Engl J Med; 2015 Jan; 372(5):418-25. PubMed ID: 25629740
[TBL] [Abstract][Full Text] [Related]
4. Treatment of ACEI-related angioedema with icatibant: a case series.
Bova M; Guilarte M; Sala-Cunill A; Borrelli P; Rizzelli GM; Zanichelli A
Intern Emerg Med; 2015 Apr; 10(3):345-50. PubMed ID: 25666515
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383
[TBL] [Abstract][Full Text] [Related]
7. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
Fast S; Henningsen E; Bygum A
Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
[TBL] [Abstract][Full Text] [Related]
8. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
Fok JS; Katelaris CH; Brown AF; Smith WB
Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
[TBL] [Abstract][Full Text] [Related]
9. Treatment of angiotensin receptor blocker-induced angioedema: A case series.
Strassen U; Bas M; Hoffmann TK; Knopf A; Greve J
Laryngoscope; 2015 Jul; 125(7):1619-23. PubMed ID: 25646708
[TBL] [Abstract][Full Text] [Related]
10. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
Schmidt PW; Hirschl MM; Trautinger F
J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347
[No Abstract] [Full Text] [Related]
11. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
[TBL] [Abstract][Full Text] [Related]
12. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
Jeon J; Lee YJ; Lee SY
J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
[No Abstract] [Full Text] [Related]
14. [Bradykinin-mediated angioedema secondary to angiotensin converting enzyme: initiate treatment from the prehospital phase].
Javaud N; Fain O; Bernot B; Adnet F; Lapostolle F
Ann Fr Anesth Reanim; 2011 Nov; 30(11):848-50. PubMed ID: 21978477
[TBL] [Abstract][Full Text] [Related]
15. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
Culley CM; DiBridge JN; Wilson GL
Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
[TBL] [Abstract][Full Text] [Related]
16. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
Sinert R; Levy P; Bernstein JA; Body R; Sivilotti MLA; Moellman J; Schranz J; Baptista J; Kimura A; Nothaft W;
J Allergy Clin Immunol Pract; 2017; 5(5):1402-1409.e3. PubMed ID: 28552382
[TBL] [Abstract][Full Text] [Related]
17. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
[TBL] [Abstract][Full Text] [Related]
18. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
Zanichelli A; Bova M; Coerezza A; Petraroli A; Triggiani M; Cicardi M
Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628
[TBL] [Abstract][Full Text] [Related]
19. Icatibant for the treatment of hereditary angioedema.
Cole SW; Lundquist LM
Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.
Scalese MJ; Reinaker TS
Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]